{"id":"tp-53970","type":"article-newspaper","title":"PepGen Shares Rise 92.9% After Phase 2 Myotonic Dystrophy Results","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/53970","datePublished":"2026-11-11T12:54:08.000Z","dateModified":"2026-11-11T12:54:08.000Z","language":"en","abstract":"Six participants receiving 10 mg/kg had mean muscle RNA splicing correction of 46.5% at week 13. January extension data will cover clinical results at 5 mg/kg and safety at 10 mg/kg.","section":"Business","references":[]}